Mashhadani to Asharq Al-Awsat: Regional Coordination Needed to Prevent Syria’s Division

Mashhadani during a parliamentary session (Iraqi Parliament website)
Mashhadani during a parliamentary session (Iraqi Parliament website)
TT

Mashhadani to Asharq Al-Awsat: Regional Coordination Needed to Prevent Syria’s Division

Mashhadani during a parliamentary session (Iraqi Parliament website)
Mashhadani during a parliamentary session (Iraqi Parliament website)

Iraqi Parliament Speaker Mahmoud al-Mashhadani has called for high-level coordination among key regional players—including Iraq, Saudi Arabia, and other nations—to avert one of the most dangerous scenarios facing Syria: the threat of division, which he described as “one of Israel’s objectives.”

In an interview with Asharq Al-Awsat, Mashhadani discussed the Syrian crisis and its impact on Iraq and the broader region. He explained that the current Syrian situation has unfolded with unforeseen tools, timing, and external support, yet remains controlled and deliberate.

According to the Iraqi official, Syria faces three possible outcomes: stability, chaos, or division.

“Who supports the division of Syria?” he asked, saying “Israel alone, while key nations in the region—such as Iran, Türkiye, Egypt, Saudi Arabia, Iraq, and Jordan—oppose it.”

He urged these nations to overcome their differences and coordinate to prevent Syria’s fragmentation and maintain its stability, saying: “We must prioritize the unity of Syria over our disputes.”

Mashhadani emphasized Iraq’s efforts to mediate and foster understanding among these countries, saying “Iraq has a unique historical opportunity to reclaim its regional role.”

He explained that Iraq’s strategic position as a crossroads between major nations enables it to facilitate dialogue and cooperation. He also stressed the importance of high-level security coordination, citing shared concerns over threats such as the Kurdistan Workers’ Party (PKK) and ISIS.

“We all share common fears regarding the spread of extremist groups,” he said, “and Iraq can act as a coordinator to address these concerns.”

Additionally, he called for Iraq to collaborate with Gulf countries to address legitimate fears regarding Syria’s future governance and potential domination by extremist groups.

“We must ask: who will govern Syria, and how do we prevent the rise of radical forces like the Muslim Brotherhood?”

Mashhadani highlighted the unified rejection by Iraq, Jordan, Egypt, and Saudi Arabia of plans to forcibly relocate Palestinians from the West Bank to Sinai, Jordan, or Iraq.

“This displacement scheme is unacceptable to us and to the region,” he affirmed.

On Iraq, Mashhadani confirmed that the parliamentary elections are set to take place in October, in line with agreements among political blocs. He also emphasized the need for national unity, saying: “Iraq needs a leadership umbrella that represents the entire nation, and parliament is best suited to fulfill this role.”

He further stated that his political agenda centers on rebuilding and uniting Iraq’s Sunni community, which has faced significant challenges since 2014.

“My mission is to bring together the different Sunni factions, despite their rivalries and conflicting interests,” he said. “I aim to serve as an umbrella figure—a stabilizing presence to guide them toward cohesion and cooperation.”

Revisiting his 2014 proposal for “national reconciliation,” Mashhadani stressed the importance of transitioning Iraq from a system based on sectarian divisions to one grounded in citizenship, where merit and competence prevail.

“We asked ourselves: what kind of Iraq do we want?” he recalled. “The answer was clear—an Iraq that transitions from a state of components to a state of citizenship.” However, the initiative was sidelined due to political events, including the 2018 protests. “The need for reconciliation is more urgent than ever,” he concluded.

Mashhadani dismissed recurring calls for the creation of a Sunni federal region as “political immaturity.” Reflecting on a similar proposal for a nine-province Shiite federal region in 2006, he reiterated his opposition to dividing Iraq.

He distinguished between federalism and division, saying: “Federalism is a promising concept, but it requires deep understanding and experience. Division, on the other hand, would be disastrous.”

“Iraq’s diversity makes unity our only viable path forward. Citizenship must be the foundation of our state," he added.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.